Phreesia, Inc.
PHR Healthcare Health Information Services
Phreesia, Inc.’s revenue for fiscal 2026 (year ended January 2026) was $480.6 million, up 14.5% from fiscal 2025. In the quarter to July 2026, revenue grew 10.4%, EPS grew 200.0%, free cash flow grew 43.5% and total debt rose 3,191.9%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.
Follow PHR
Phreesia, Inc. (PHR) P/E ratio
As of 16 October 2026, Phreesia, Inc. (PHR) trades at a P/E ratio of 64.4×. Over the past ten years it has ranged from 0.0× (January 2026) to 440× (February 2026); the current reading is higher than 94% of that period. That is above the Health Information Services industry median of 39.8× and above the Healthcare sector median of 23.0×.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2026 | 440× | — |
| FY2025 | 0.0× | — |
| FY2024 | 0.0× | — |
| FY2023 | 0.0× | — |
| FY2022 | 0.0× | — |
| FY2021 | 0.0× | — |
| FY2020 | 0.0× | — |
| FY2019 | 0.0× | — |
| FY2018 | 0.0× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jul 2026 | 63.1× | 2.80% |
| Apr 2026 | 61.4× | (86.06%) |
| Jan 2026 | 440× | — |
| Oct 2025 | 0.0× | — |
| 28 more quarters | Free account |
Against its own ten years
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| MDRX Veradigm Inc. compare | n/m |
| SOPH SOPHiA GENETICS SA compare | n/m |
| EVH Evolent Health, Inc compare | n/m |
| WEAV Weave Communications, Inc. compare | n/m |
| TDOC Teladoc Health, Inc. compare | n/m |
| HSTM HealthStream, Inc. compare | 46.0× |
| PHR Phreesia, Inc. | 64.4× |
| NRC National Research Corporation compare | 80.6× |
| OMDA Omada Health, Inc. compare | 252× |
| Health Information Services industry median | 39.8× |
| Healthcare sector median | 23.0× |
| Market median | 18.1× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)